Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

UK Regulators Approve Phase 2/3 Study of Opaganib for COVID-19

ContagionLive - Opaganib is set to be evaluated against SARS-CoV-2 in a multi-center, randomized, parallel arm, double-blind, placebo-controlled study.

Read the full article here